Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer.

Patients who opt for no adjuvant therapy, or who do not tolerate ET, are at increased risk of disease recurrence if they omit RT. Clinicians should consider the likelihood a patient will adhere to ET prior to recommending omission of RT.